Bayer has started a phase 3 trial of its intrauterine contraceptive Mirena in an endometrial condition that can lead to complications, including cancer, but has no approved therapies. The condition – ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback